On August 11, 2023, Elevar Therapeutics, Inc. closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
59,600 KRW | +3.11% | -7.88% | +17.55% |
1st Jan change | Capi. | |
---|---|---|
+17.55% | 5.49B | |
-6.57% | 180B | |
-0.53% | 109B | |
-3.37% | 68.93B | |
-4.41% | 46.41B | |
+12.83% | 45.43B | |
+7.38% | 43.26B | |
+19.45% | 30.05B | |
+16.10% | 25.19B | |
-7.35% | 23.34B |
- Stock Market
- Equities
- A028300 Stock
- News HLB Co., Ltd.
- Elevar Therapeutics, Inc. announced that it has received KRW 58.174676146 billion in funding from HLB Co., Ltd.